Complex biophysical changes and reduced neuronal firing in an SCN8A variant associated with developmental delay and epilepsy
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved..
Mutations in the SCN8A gene, encoding the voltage-gated sodium channel NaV1.6, are associated with a range of neurodevelopmental syndromes. The p.(Gly1625Arg) (G1625R) mutation was identified in a patient diagnosed with developmental epileptic encephalopathy (DEE). While most of the characterized DEE-associated SCN8A mutations were shown to cause a gain-of-channel function, we show that the G1625R variant, positioned within the S4 segment of domain IV, results in complex effects. Voltage-clamp analyses of NaV1.6G1625R demonstrated a mixture of gain- and loss-of-function properties, including reduced current amplitudes, increased time constant of fast voltage-dependent inactivation, a depolarizing shift in the voltage dependence of activation and inactivation, and increased channel availability with high-frequency repeated depolarization. Current-clamp analyses in transfected cultured neurons revealed that these biophysical properties caused a marked reduction in the number of action potentials when firing was driven by the transfected mutant NaV1.6. Accordingly, computational modeling of mature cortical neurons demonstrated a mild decrease in neuronal firing when mimicking the patients' heterozygous SCN8A expression. Structural modeling of NaV1.6G1625R suggested the formation of a cation-π interaction between R1625 and F1588 within domain IV. Double-mutant cycle analysis revealed that this interaction affects the voltage dependence of inactivation in NaV1.6G1625R. Together, our studies demonstrate that the G1625R variant leads to a complex combination of gain and loss of function biophysical changes that result in an overall mild reduction in neuronal firing, related to the perturbed interaction network within the voltage sensor domain, necessitating personalized multi-tiered analysis for SCN8A mutations for optimal treatment selection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1870 |
|---|---|
| Enthalten in: |
Biochimica et biophysica acta. Molecular basis of disease - 1870(2024), 5 vom: 20. März, Seite 167127 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Quinn, Shir [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biophysical analysis |
|---|
| Anmerkungen: |
Date Revised 28.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.bbadis.2024.167127 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370085744 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370085744 | ||
| 003 | DE-627 | ||
| 005 | 20240330001407.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240324s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbadis.2024.167127 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1355.xml |
| 035 | |a (DE-627)NLM370085744 | ||
| 035 | |a (NLM)38519006 | ||
| 035 | |a (PII)S0925-4439(24)00116-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Quinn, Shir |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Complex biophysical changes and reduced neuronal firing in an SCN8A variant associated with developmental delay and epilepsy |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Mutations in the SCN8A gene, encoding the voltage-gated sodium channel NaV1.6, are associated with a range of neurodevelopmental syndromes. The p.(Gly1625Arg) (G1625R) mutation was identified in a patient diagnosed with developmental epileptic encephalopathy (DEE). While most of the characterized DEE-associated SCN8A mutations were shown to cause a gain-of-channel function, we show that the G1625R variant, positioned within the S4 segment of domain IV, results in complex effects. Voltage-clamp analyses of NaV1.6G1625R demonstrated a mixture of gain- and loss-of-function properties, including reduced current amplitudes, increased time constant of fast voltage-dependent inactivation, a depolarizing shift in the voltage dependence of activation and inactivation, and increased channel availability with high-frequency repeated depolarization. Current-clamp analyses in transfected cultured neurons revealed that these biophysical properties caused a marked reduction in the number of action potentials when firing was driven by the transfected mutant NaV1.6. Accordingly, computational modeling of mature cortical neurons demonstrated a mild decrease in neuronal firing when mimicking the patients' heterozygous SCN8A expression. Structural modeling of NaV1.6G1625R suggested the formation of a cation-π interaction between R1625 and F1588 within domain IV. Double-mutant cycle analysis revealed that this interaction affects the voltage dependence of inactivation in NaV1.6G1625R. Together, our studies demonstrate that the G1625R variant leads to a complex combination of gain and loss of function biophysical changes that result in an overall mild reduction in neuronal firing, related to the perturbed interaction network within the voltage sensor domain, necessitating personalized multi-tiered analysis for SCN8A mutations for optimal treatment selection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Biophysical analysis | |
| 650 | 4 | |a Developmental epileptic encephalopathy | |
| 650 | 4 | |a G1625R | |
| 650 | 4 | |a Neuronal and structural modeling | |
| 650 | 4 | |a Patch-clamp | |
| 650 | 4 | |a SCN8A | |
| 700 | 1 | |a Zhang, Nan |e verfasserin |4 aut | |
| 700 | 1 | |a Fenton, Timothy A |e verfasserin |4 aut | |
| 700 | 1 | |a Brusel, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Muruganandam, Preethi |e verfasserin |4 aut | |
| 700 | 1 | |a Peleg, Yoav |e verfasserin |4 aut | |
| 700 | 1 | |a Giladi, Moshe |e verfasserin |4 aut | |
| 700 | 1 | |a Haitin, Yoni |e verfasserin |4 aut | |
| 700 | 1 | |a Lerche, Holger |e verfasserin |4 aut | |
| 700 | 1 | |a Bassan, Haim |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Yuanyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Ben-Shalom, Roy |e verfasserin |4 aut | |
| 700 | 1 | |a Rubinstein, Moran |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biochimica et biophysica acta. Molecular basis of disease |d 2017 |g 1870(2024), 5 vom: 20. März, Seite 167127 |w (DE-627)NLM260137588 |x 1879-260X |7 nnns |
| 773 | 1 | 8 | |g volume:1870 |g year:2024 |g number:5 |g day:20 |g month:03 |g pages:167127 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbadis.2024.167127 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 1870 |j 2024 |e 5 |b 20 |c 03 |h 167127 | ||